Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 10
Submit an article Journal homepage
397
Views
10
CrossRef citations to date
0
Altmetric
Letter

Lenalidomide: a new treatment option for Castleman disease

Petr SzturzDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech RepublicCorrespondence[email protected]
,
Zdeněk AdamDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
,
Jana ChovancováFaculty of Medicine of Masaryk University, Brno, Czech Republic
,
Olga StehlíkováDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
,
Martin KlabusayDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
,
Zdeněk ŘehákDepartment of Nuclear Medicine, PET Center at the Masaryk Memorial Cancer Institute, Brno, Czech Republic
,
Renata KoukalováDepartment of Nuclear Medicine, PET Center at the Masaryk Memorial Cancer Institute, Brno, Czech Republic
,
Marta KrejčíDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
,
Luděk PourDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
,
Lenka ZahradováDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
,
Roman HájekDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
&
Jiří MayerDepartment of Internal Medicine – Hematooncology, Faculty of Medicine of Masaryk University and University Hospital Brno, Czech Republic
 show all
Pages 2089-2091 | Received 17 Jul 2011, Accepted 04 Sep 2011, Published online: 05 Dec 2011

References

  • Castleman B, Towne VW. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot. N Engl J Med 1954;251:396–400.
  • Ye B, Gao SG, Li W, . A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients. Med Oncol 2010;27:1171–1178.
  • Van Rhee F, Stone K, Szmania S, . Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010;8:486–498.
  • Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005;129:3–17.
  • Yabuhara A, Yanagisawa M, Murata T, . Giant lymph node hyperplasia (Castleman's disease) with spontaneous production of high levels of B-cell differentiation factor activity. Cancer 1989;63: 260–265.
  • Matsuyama M, Suzuki T, Tsuboi H, . Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Intern Med 2007;46:771–774.
  • Palumbo A, Rajkumar SV. Multiple myeloma: chemotherapy or transplantation in the era of new drugs. Eur J Haematol 2010;84: 379–390.
  • Jung CP, Emmerich B, Goebel FD, . Successful treatment of a patient with HIV-associated multicentric Castleman disease (MCD) with thalidomide. Am J Hematol 2004;75:176–177.
  • Lee FC, Merchant SH. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide. Am J Hematol 2003;73:48–53.
  • Starkey CR, Joste NE, Lee FC. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide. Am J Hematol 2006;81:303–304.
  • Stary G, Kohrgruber N, Herneth AM, . Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide. AIDS 2008;22:1232–1234.
  • Kim SY, Lee SA, Ryoo HM, . Thalidomide for POEMS syndrome. Ann Hematol 2006;85:545–546.
  • Menegato MA, Canelles MF, Tonutti E, . Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease. Clin Nephrol 2004;61:352–356.
  • Miltenyi Z, Toth J, Gonda A, . Successful immunomodulatory therapy in Castleman disease with paraneoplastic pemphigus vulgaris. Pathol Oncol Res 2009;15:375–381.
  • Vallet S, Palumbo A, Raje N, . Thalidomide and lenalidomide: mechanism-based potential drug combinations. Leuk Lymphoma 2008;49:1238–1245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.